Introduction {#s1}
============

Schistosomiasis, chronic infection with parasitic *Schistosoma* worms, affects at least 200 million people worldwide, and may rival malaria in terms of socioeconomic impact in endemic regions [@pntd.0001912-King1]. The two main forms of schistosomiasis are hepatoenteric and urogenital, caused primarily by *Schistosoma mansoni* and *Schistosoma haematobium*, respectively. In both forms of schistosomiasis, the tropism of adult worms for particular vascular beds (mesenteric or pelvic) determines where oviposition occurs. Deposited eggs trigger florid tissue inflammation that is believed to cause much of the morbidity of infection. For example, *S. haematobium* oviposition in the bladder and genital tract results in hematuria, urinary tract fibrosis (sometimes leading to obstructive renal failure), increased susceptibility to HIV infection, and enhanced risk of bladder cancer. Van der Werf et al. estimated that in a 2 week period in 2000, 70 and 32 million individuals in sub-Saharan Africa experienced hematuria and dysuria associated with *S. haematobium* infection, respectively [@pntd.0001912-vanderWerf1]. Significant *S. haematobium*-triggered bladder wall pathology and severe hydronephrosis were predicted to afflict 18 and 10 million people, respectively. Urogenital schistosomiasis appears to predispose individuals to earlier onset and more aggressive bladder cancers [@pntd.0001912-Group1], [@pntd.0001912-Bedwani1]. Moreover, an estimated 150,000 deaths are attributable annually to *S. haematobium*-induced obstructive renal failure alone. Consequently, urogenital schistosomiasis is one of the most important causes of helminth-related mortality worldwide.

Despite the importance of this infection, the mechanisms by which urogenital schistosomiasis leads to these sequelae are poorly defined, particularly in the early stages of infection. This deficiency in knowledge is due largely to the lack of suitable animal models for *S. haematobium* infection [@pntd.0001912-Rollinson1]. Natural transdermal infection of mice or other rodents (e.g., hamsters) with *S. haematobium* cercariae typically results in hepatoenteric rather than urogenital disease [@pntd.0001912-Loker1]--[@pntd.0001912-Vuong1]. Non-human primates recapitulate human disease but are expensive and controversial to use as animal models [@pntd.0001912-Ordan1]. Both hamster and primate models suffer from having few species-specific tools.

To address the dearth of good animal models for urogenital schistosomiasis we recently developed a novel mouse model of *S. haematobium* egg-induced immunopathology [@pntd.0001912-Fu1]. In this model, a single direct injection of *S. haematobium* eggs into the bladder walls of mice recapitulates multiple aspects of human disease, including a regional and systemic Type 2 immune response, development of bladder granulomata, hematuria, bladder fibrosis, egg shedding, and urothelial hyperplasia. We sought to leverage this model to determine the early molecular events in the bladder occurring after introduction of *S. haematobium* eggs, as well as the temporal evolution of these processes. Microarray analysis demonstrated time-dependent, differential transcription of large numbers of genes. Many differentially transcribed genes were related to the canonical Type 2 anti-schistosomal immune response, collagen and metalloproteinase activity, urothelial barrier functions, and carcinogenesis pathways. Taken together, our findings have important implications for understanding host-parasite interactions and carcinogenesis in urogenital schistosomiasis, and may provide clues for novel therapeutic strategies for this disease and perhaps bladder cancer and bladder inflammatory disorders in general.

Materials and Methods {#s2}
=====================

Ethics statement {#s2a}
----------------

All animal work was conducted according to relevant U.S. and international guidelines. Specifically, all experimental procedures were carried out in accordance with the Administrative Panel on Laboratory Animal Care (APLAC) protocol and the institutional guidelines set by the Veterinary Service Center at Stanford University (Animal Welfare Assurance A3213-01 and USDA License 93-4R-00). Stanford APLAC and institutional guidelines are in compliance with the U.S. Public Health Service Policy on Humane Care and Use of Laboratory Animals. The Stanford APLAC approved the animal protocol associated with the work described in this publication.

*S. haematobium* egg isolation {#s2b}
------------------------------

*S. haematobium*-infected LVG hamsters were obtained from the National Institute of Allergy and Infectious Diseases Schistosomiasis Resource Center of the National Institutes of Health. Eggs were isolated from hamsters as previously described [@pntd.0001912-Fu1]. In brief, hamsters were sacrificed at 18 weeks post-infection, at which time livers and intestines were minced, homogenized in a Waring blender, resuspended in 1.2% NaCl containing antibiotic-antimycotic solution (100 units Penicillin, 100 µg/mL Streptomycin and 0.25 µg/mL Amphotericin B, Sigma-Aldrich), passed through a series of stainless steel sieves with sequentially decreasing pore sizes (450 µm, 180 µm, and 100 µm), and finally retained on a 45 µm sieve.

*S. haematobium* egg injection {#s2c}
------------------------------

Egg injections of the mouse bladder wall were performed as previously described [@pntd.0001912-Fu1], [@pntd.0001912-Fu2]. Specifically, 7 to 8 week-old female BALB/c mice (Jackson Laboratories) were anesthetized with isoflurane, a midline lower abdominal incision was made, and the bladder exteriorized. Freshly prepared *S. haematobium* eggs (3,000 eggs in 50 µl of phosphate-buffered saline, experimental group) or uninfected hamster liver and intestinal extract (in 50 µl of phosphate-buffered saline, control group) was injected submucosally into the anterior aspect of the bladder dome. Abdominal incisions were then closed with 4-0 Vicryl suture, and the surgical site was treated once with topical antibiotic ointment. Mice were sacrificed at 1, 3, and 5 weeks post-injection (n = 3 for each time point/treatment group \[egg vs. vehicle\])

Micro-ultrasonography {#s2d}
---------------------

Mouse bladder micro-ultrasonography was performed as previously described [@pntd.0001912-Fu1]. At various time points after bladder wall injection, mice were anesthetized using vaporized isoflurane and their abdominal walls were depilated. Transabdominal images of the bladder were then obtained using a VisualSonics Vevo 770 high-resolution ultrasound micro-imaging system with an RMV 704 scanhead \[40 MHz\] (Small Animal Imaging Facility, Stanford Center for Innovation in In-Vivo Imaging).

Bladder histopathologic analysis {#s2e}
--------------------------------

Mice were sacrificed after bladder wall injection, and bladders processed for routine histology. Five µm sections were stained with hematoxylin and eosin or Masson\'s Trichrome-stained sections.

Arginase-1 immunohistochemistry {#s2f}
-------------------------------

Bladders were removed from mice and placed in 10% phosphate-buffered formalin for 18 hours before dehydration and embedding in paraffin. Serial 5 µm sections were cut using a microtome, placed on positively charged glass slides and dried overnight at 56°C. Sections were heated to 100°C in citric acid buffer (pH 6.0) for 15 minutes. Endogenous peroxidase activity was blocked using 0.3% hydrogen peroxidase in methanol. An avidin-biotin complex immunoperoxidase protocol was employed, including staining of sections with anti-arginase-1 antibody (Clone 19/Arginase I, BD Biosciences) at a dilution of 1∶1000, biotinylated anti-mouse IgG1 at 1∶1000(BioLegend). Next, sections were incubated with streptavidin labeled horseradish peroxidase (Biocare Medical, Concord, CA) followed by use of a DAB chromogen substrate kit (Biocare Medical, Concord, CA) and counterstaining with hematoxylin.

Bladder microarray analysis {#s2g}
---------------------------

Mice were sacrificed and bladders were immediately collected and preserved in RNA Later (Ambion) at −80°C. RNA was extracted for each individual bladder by Trizol Reagent (Ambion) and was reverse transcribed to cDNA. RNA yields were measured using a QuBit 2.0 Fluorimeter (Life Technologies, Grand Island, NY, USA) and quality was assessed using an Agilent Bioanalyzer and RNA 6000 Nano Labchips (Agilent Technologies, Foster City, USA). Next, individual bladder cDNA was *in vitro* transcribed to synthesize cRNA using Illumina TotalPrep RNA Amplification Kits (Ambion, Applied Biosystems, Foster City, CA), and hybridized using standard Illumina protocols on the MouseWG-6 v2.0 chip (Stanford Functional Genomics Facility, Stanford, CA). Illumina Beadstation-generated scanned array files were filtered and normalized (quantile method) in GeneSpring GX version 11. Genes in egg- versus control vehicle-injected bladders were considered differentially transcribed at various time points if they were transcribed ≥2-fold and p\<0.05 by unpaired T-test. Functional annotation of differentially transcribed genes was performed using DAVID (DAVID Bioinformatics Resources 6.7, National Institute of Allergy and Infectious Diseases \[NIAID\], NIH) in combination with the Biocarta and KEGG pathway databases [@pntd.0001912-Dennis1], [@pntd.0001912-Huang1].

Real-time PCR {#s2h}
-------------

Mice were sacrificed after bladder wall injection, and bladder RNA preserved and isolated as above. RNA yields and quality were measured as above. cDNA was synthesized from the RNA of individual mouse bladders. Primer sequences for genes of interest were obtained from PrimerBank (<http://pga.mgh.harvard.edu/primerbank/>). ([Table S3](#pntd.0001912.s003){ref-type="supplementary-material"}) GAPDH was used as a housekeeping gene. Real-time PCR was performed using SYBR Green and an Mx3005p thermal cycler (Stratagene). Cycle thresholds (Ct) were calculated for each reaction. Using the comparative Ct method relative gene transcription was calculated as 2^−ΔΔCt^, where ΔCt = Ct (gene of interest) - ΔCt (normalizer = β-actin). ΔΔCt was calculated as ΔCt (egg-injected) - ΔCt (calibrator). Correlations between microarray and real-time PCR results were assessed using Spearman\'s Rho measure of correlation in Microsoft Excel 2010 for Windows.

Results {#s3}
=======

Delivery of *S. haematobium* eggs to the bladder triggers time-dependent, differential gene transcription {#s3a}
---------------------------------------------------------------------------------------------------------

Microarray-based comparisons of *S. haematobium* egg- versus control vehicle-injected bladders demonstrated differential gene transcription over time ([Figure 1](#pntd-0001912-g001){ref-type="fig"} and [Table S1](#pntd.0001912.s001){ref-type="supplementary-material"}). At one week post-egg injection, 279 and 22 genes featured significantly more and less transcription (≥2-fold and p\<0.05), respectively. By three weeks post-injection, more genes were differentially transcribed, with 1001 and 570 genes demonstrating more and less transcription, respectively. At five weeks post-injection, fewer genes demonstrated altered transcription, with 794 and 308 genes exhibiting more and less transcription, respectively. Functional annotation clustering of genes featuring ≥2-fold differential transcription indicated that each of these gene clusters was associated with a discrete gene ontology ([Table S2](#pntd.0001912.s002){ref-type="supplementary-material"}). Many of these clusters were related to immune responses. Illumina probe IDs and Entrez Gene IDs of selected genes are provided ([Table S1](#pntd.0001912.s001){ref-type="supplementary-material"}).

![Volcano plots of differentially transcribed genes in egg-injected bladders.\
Separate plots are shown comparing microarray-derived gene transcription in egg-injected bladders relative to control vehicle-injected bladders (A, one week post-injection; B, three weeks post-injection; C, five weeks post-injection). Log fold changes are plotted on the x-axes and negative log10 p-values are plotted on the y-axes. Red and other non-dark gray, colored symbols denote statistically significant (p\<0.05) changes in gene transcription. Gray symbols denote statistically insignificant (p\>0.05) changes in change transcription. Legend for individual, selected genes of interest applies to all three panels. For clarity, each selected gene of interest with multiple microarray probes has been denoted using the probe featuring the greatest differential signal for that gene.](pntd.0001912.g001){#pntd-0001912-g001}

Validation of a subset of the microarray data was performed using real-time PCR ([Figure 2](#pntd-0001912-g002){ref-type="fig"}). Specifically, genes related to inflammation (IL4, CCL2, CCL11, inducible nitric oxide synthase \[iNOS\], arginase-1, and CD68), urothelial function (uroplakins 1A, 1B, 2, 3A, and 3B and claudin-8), and collagen (collagen type 3α1, 4α5, and 17 α1) were assayed. Overall, correlations between microarray and PCR findings were tight, with Spearman\'s correlation r = 0.87, 0.94, and 0.84 at 1, 3, and 5 weeks post-injection, respectively.

![Real-time PCR corroboration of gene transcription profiles obtained by microarray analysis.\
Transcription of a subset of genes analyzed by real-time PCR is depicted in the scatter plots and is displayed as fold change relative to control-injected bladders at 1, 3 and 5 weeks post-injection. Colored bars correspond to microarray data, with decreased, increased, and unchanged transcription colored green, red, and black, respectively. Increasing intensity of green and red bars indicates more extreme changes in transcription (up to \>20-fold). \* = p\<0.05, \*\* = p\<0.01, \*\*\*p\<0.001 in comparison to control vehicle-injected bladders (or across time points if annotated with brackets). UPK3A: uroplakin 3a, CLDN8: claudin-8, COL4A5: collagen type 4 alpha 5, COL17A1: collagen type 17 alpha 1, NOS2: inducible nitric oxide synthase, UPK3B: uroplakin 3b, UPK1B: uroplakin 1b, UPK1A: uroplakin 1a, UPK2: uroplakin 2, ARG1: arginase-1.](pntd.0001912.g002){#pntd-0001912-g002}

*S. haematobium* eggs induce bladder transcription of granulomatous, Type 2 inflammation-associated genes {#s3b}
---------------------------------------------------------------------------------------------------------

Bladder wall injection with *S. haematobium* eggs induced increased transcription of numerous genes related to granulomatous inflammation and type 2 immunity (selected examples in [Table 1](#pntd-0001912-t001){ref-type="table"}). Specific genes which exhibited increased transcription included cytokine and cytokine-related genes such as IL-4, IL-4-induced 1, IL-1β, IL-6, interferon gamma-inducible proteins (IFI30 and IFI47), TGF-β, IL-13 receptor alpha 2, IL-10 receptor alpha, and cytokine inducible SH2-containing protein (CISH); markers of macrophages including macrophage-expressed gene 1 (MPEG1, general macrophage marker), and arginase, Ym1 (CHI3L3), and mannose receptor C type 1 (all alternatively activated macrophage markers); and chemokines such as CCL4 (MIP-1 beta), CCL5 (RANTES), CCL11 (eotaxin) and CXCL1 (KC). In fact, KEGG pathways analysis confirmed that one of the biological clusters featuring the greatest number of differentially transcribed genes at one and three weeks post-egg injection was "cytokine-cytokine receptor pathways" (1 week: 15 genes, 3 weeks: 41 genes, [Tables 2](#pntd-0001912-t002){ref-type="table"} and [3](#pntd-0001912-t003){ref-type="table"}). By 5 weeks post-egg injection, the biological cluster with the greatest number of differentially transcribed genes (26) was "B cell receptor signaling pathway" ([Table 4](#pntd-0001912-t004){ref-type="table"}). Accordingly, numerous IgG and IgE Fc receptor genes featured increased transcription. Other immune response-related genes exhibiting differential transcription included those encoding for eosinophil ribonucleases, C1q, arachidonate 15-lipoxygenase (ALOX15), and platelet thromboxane A synthase 1 (TBXAS1).

10.1371/journal.pntd.0001912.t001

###### Increased transcription of granulomatous and type 2 inflammation genes identified through microarray analysis.

![](pntd.0001912.t001){#pntd-0001912-t001-1}

  Gene       Fold-Regulation Post-Injection Relative to Control[\*](#nt101){ref-type="table-fn"}                                                                              
  --------- ------------------------------------------------------------------------------------- ------------------------------------- ------------------------------------- -------------------------------------
  IL4                                                                                              [\*\*](#nt102){ref-type="table-fn"}                 3.48197                               3.03925
  IL4I1                                                                                                          4.62434                               8.84372                              9.386889
  IL1B                                                                                                           6.73795                              10.05383                 [\*\*](#nt102){ref-type="table-fn"}
  IL6                                                                                              [\*\*](#nt102){ref-type="table-fn"}                3.294366                 [\*\*](#nt102){ref-type="table-fn"}
  TGFB                                                                                             [\*\*](#nt102){ref-type="table-fn"}                 2.2158                  [\*\*](#nt102){ref-type="table-fn"}
  ARG1                                                                                             [\*\*](#nt102){ref-type="table-fn"}                 21.9539                               7.41649
  CCL4                                                                                             [\*\*](#nt102){ref-type="table-fn"}                 3.37419                 [\*\*](#nt102){ref-type="table-fn"}
  CCL5                                                                                             [\*\*](#nt102){ref-type="table-fn"}   [\*\*](#nt102){ref-type="table-fn"}                2.605253
  CCL11                                                                                            [\*\*](#nt102){ref-type="table-fn"}                 5.88034                              3.112205
  CXCL1                                                                                                          2.27438                               3.28179                 [\*\*](#nt102){ref-type="table-fn"}
  IFI30                                                                                            [\*\*](#nt102){ref-type="table-fn"}                2.545283                              2.864982
  IFI47                                                                                                         2.318303                              2.252061                 [\*\*](#nt102){ref-type="table-fn"}
  IL13RA2                            [\*\*](#nt102){ref-type="table-fn"}                                        5.486401                              3.557954                
  IL10RA                                          2.014572                                                      3.834927                              3.070781                
  CISH                                                                                             [\*\*](#nt102){ref-type="table-fn"}                2.600125                 [\*\*](#nt102){ref-type="table-fn"}
  ALOX15                             [\*\*](#nt102){ref-type="table-fn"}                                        3.397949                              2.748778                
  TBXAS1                                          2.698519                                                       2.63449                 [\*\*](#nt102){ref-type="table-fn"}  
  MPEG1                              [\*\*](#nt102){ref-type="table-fn"}                           [\*\*](#nt102){ref-type="table-fn"}                2.090888                
  CHI3L3                             [\*\*](#nt102){ref-type="table-fn"}                                        25.39334                               6.99343                
  MRC1                                                                                                          2.973735                              2.644192                 [\*\*](#nt102){ref-type="table-fn"}

All values ≥2-fold and p\<0.05.

Value \<2-fold and/or p≥0.05.

10.1371/journal.pntd.0001912.t002

###### KEGG pathways analysis reveals extensive cytokine-cytokine receptor interactions in the bladder one week post-egg exposure.

![](pntd.0001912.t002){#pntd-0001912-t002-2}

  Entrez Gene ID                              Gene Name
  ---------------- ---------------------------------------------------------------
  100048556               chemokine (C-C motif) ligand 12; similar to MCP-5
  56221                            chemokine (C-C motif) ligand 24
  20306                            chemokine (C-C motif) ligand 7
  20308                            chemokine (C-C motif) ligand 9
  14825                           chemokine (C-X-C motif) ligand 1
  12978                         colony stimulating factor 1 receptor
  12984             CSF 2 receptor, beta 2, low-affinity (granulocyte-macrophage)
  16178                            interleukin 1 receptor, type II
  16154                            interleukin 10 receptor, alpha
  16156                                    interleukin 11
  12765                             interleukin 8 receptor, beta
  18413                                     oncostatin M
  12986                     predicted gene 4223; similar to Csf3r protein
  100044702                  similar to LPS-induced CXC chemokine; CXCL5
  18383                TNF receptor superfamily, member 11b (osteoprotegerin)

All genes shown featured ≥2-fold differential transcription and p\<0.05.

10.1371/journal.pntd.0001912.t003

###### KEGG pathways analysis reveals extensive cytokine-cytokine receptor interactions in the bladder three weeks post-egg exposure.

![](pntd.0001912.t003){#pntd-0001912-t003-3}

  Entrez Gene ID                                Gene Name
  ------------------ ---------------------------------------------------------------
  21940                                       CD27 antigen
  21939                                       CD40 antigen
  20292                              chemokine (C-C motif) ligand 11
  100048556                 chemokine (C-C motif) ligand 12; similar to MCP-5
  18829                             chemokine (C-C motif) ligand 21A
  20303                              chemokine (C-C motif) ligand 4
  20306                              chemokine (C-C motif) ligand 7
  20308                              chemokine (C-C motif) ligand 9
  12774                             chemokine (C-C motif) receptor 5
  12458                             chemokine (C-C motif) receptor 6
  12775                             chemokine (C-C motif) receptor 7
  14825                             chemokine (C-X-C motif) ligand 1
  66102                             chemokine (C-X-C motif) ligand 16
  80901                            chemokine (C-X-C motif) receptor 6
  12978                           colony stimulating factor 1 receptor
  12984               CSF 2 receptor, beta 2, low-affinity (granulocyte-macrophage)
  12983                CSF 2 receptor, beta, low-affinity (granulocyte-macrophage)
  16323                                      inhibin beta-A
  16178                              interleukin 1 receptor, type II
  16154                              interleukin 10 receptor, alpha
  16156                                      interleukin 11
  329244                                     interleukin 19
  93672                                      interleukin 24
  16189                               interleukin 4 receptor, alpha
  16190                                       interleukin 4
  16193                                       interleukin 6
  18053                  nerve growth factor receptor(TNFR superfam., member 16)
  18413                                       oncostatin M
  100041504, 65956                 similar to beta chemokine Exodus-2
  24047                         predicted chemokine (C-C motif) ligand 19
  12986                                 similar to Csf3r protein
  16186                       predicted interleukin 2 receptor, gamma chain
  57349                                pro-platelet basic protein
  100044702                    similar to LPS-induced CXC chemokine; CXCL5
  21803                            transforming growth factor, beta 1
  21943                   tumor necrosis factor (ligand) superfamily, member 11
  24099                  tumor necrosis factor (ligand) superfamily, member 13b
  72049                  tumor necrosis factor receptor superfamily, member 13c
  21935                   tumor necrosis factor receptor superfamily, member 17
  21936                   tumor necrosis factor receptor superfamily, member 18
  22163                   tumor necrosis factor receptor superfamily, member 4

All genes shown featured ≥2-fold differential transcription and p\<0.05.

10.1371/journal.pntd.0001912.t004

###### KEGG pathways analysis reveals differential transcription of multiple gene members of the B cell receptor pathway five weeks post-egg exposure.

![](pntd.0001912.t004){#pntd-0001912-t004-4}

  ENTREZ GENE ID                                          GENE NAME
  ---------------- ---------------------------------------------------------------------------------------
  17060                                                 B-cell linker
  12229                                   Bruton agammaglobulinemia tyrosine kinase
  12478                                                 CD19 antigen
  12483                                CD22 antigen; hypothetical protein LOC100047973
  12517                                                 CD72 antigen
  15985                                                 CD79B antigen
  14281                                           FBJ osteosarcoma oncogene
  14130                                      Fc receptor, IgG, low affinity IIb
  240168                                       RAS, guanyl releasing protein 3
  19354                                     RAS-related C3 botulinum substrate 2
  108723                                caspase recruitment domain family, member 11
  12902                                             complement receptor 2
  380794               immunoglobulin heavy chain 3 (serum IgG2b); Ig heavy chain (gamma polypeptide)
  16331                                    inositol polyphosphate-5-phosphatase D
  68713                                  interferon induced transmembrane protein 1
  240354                       mucosa associated lymphoid tissue lymphoma translocation gene 1
  18018                   nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
  18037             nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
  18707             phosphatidylinositol 3-kinase catalytic delta polypeptide; RIKEN cDNA 2610208K16 gene
  83490                                  phosphoinositide-3-kinase adaptor protein 1
  30955                            phosphoinositide-3-kinase, catalytic, gamma polypeptide
  234779                                          phospholipase C, gamma 2
  16061                              predicted immunoglobulin heavy chain (J558 family)
  19057                            protein phosphatase 3, catalytic subunit, gamma isoform
  15170                               protein tyrosine phosphatase, non-receptor type 6
  22324                                                vav 1 oncogene

All genes shown featured ≥2-fold differential transcription and p\<0.05.

Granuloma formation was confirmed *in vivo* by transabdominal bladder microultrasonography ([Figure 3a--b](#pntd-0001912-g003){ref-type="fig"}) and histologically by hematoxylin and eosin staining of egg-injected bladders ([Figure 3c--f](#pntd-0001912-g003){ref-type="fig"}). Finally, type 2 inflammation was verified through immunohistochemical staining for arginase-1, an enzyme strongly associated with type 2 immunity-mediated alternative activation of macrophages ([Figure 3k](#pntd-0001912-g003){ref-type="fig"}).

![Bladder wall injection with *S. haematobium* eggs triggers granuloma growth and urothelial hyperplasia.\
Intramural injection of *S. haematobium* eggs results in granuloma development. A, micro-ultrasonography of a single representative animal injected with control vehicle showing no granuloma formation; B, micro-ultrasonography of a single representative animal injected with eggs, note the presence of a bright, echogenic round granuloma (denoted by white arrow). Intramural injection of *S. haematobium* eggs initiates histologically-evident granuloma formation by one week and persisting for over five weeks (D--F), while control vehicle injection does not result in granuloma formation (C). Intramural injection of *S. haematobium* eggs induces early and sustained urothelial hyperplasia with reactive nuclear changes (1, 3, and 5 weeks post-injection, H--J), whereas control vehicle injected-bladders feature normal appearing urothelium (G). Arginase-1-specific immunohistochemistry confirms widespread expression of the enzyme in the bladder 4 weeks post-egg injection (K).](pntd.0001912.g003){#pntd-0001912-g003}

Introduction of *S. haematobium* eggs to the bladder elicits changes in urothelial function-related genes {#s3c}
---------------------------------------------------------------------------------------------------------

Delivery of *S. haematobium* eggs to the bladder prompted global decreased transcription of all uroplakin genes, in addition to several tight junction-related genes, at three weeks post-egg injection (claudins and junctional adhesion molecule-4, [Table 5](#pntd-0001912-t005){ref-type="table"}). Interestingly, this occurred in the context of egg shedding in urine ([Figure 4](#pntd-0001912-g004){ref-type="fig"}) and profound urothelial hyperplasia ([Figure 3g--j](#pntd-0001912-g003){ref-type="fig"}), a precursor lesion for bladder cancer. Indeed, pathways analysis of microarray data implicated involvement of various carcinogenesis-related signaling pathways at 5 weeks post-injection, including vascular endothelial growth factor-, oncogene-, and mammary tumor-related genes ([Tables 6](#pntd-0001912-t006){ref-type="table"}, [7](#pntd-0001912-t007){ref-type="table"}, [8](#pntd-0001912-t008){ref-type="table"}).

![*S. haematobium* eggs are shed in the urine of bladder wall-injected mice.\
Micrograph showing two intact *S. haematobium* eggs isolated from the urine of a bladder wall-injected mouse 2 weeks post-egg injection.](pntd.0001912.g004){#pntd-0001912-g004}

10.1371/journal.pntd.0001912.t005

###### Microarray analysis reveals urothelial barrier function genes with less transcription after egg exposure.

![](pntd.0001912.t005){#pntd-0001912-t005-5}

  Gene      Fold-Regulation Post-Injection Relative to Control[\*](#nt106){ref-type="table-fn"}                                                                              
  -------- ------------------------------------------------------------------------------------- ------------------------------------- ------------------------------------- ----------
  UPK2                                                                                            [\*\*](#nt107){ref-type="table-fn"}                 0.19028                 0.303506
  UPK1A                             [\*\*](#nt107){ref-type="table-fn"}                                        0.155542                              0.311607                
  UPK1B                             [\*\*](#nt107){ref-type="table-fn"}                                        0.262438                 [\*\*](#nt107){ref-type="table-fn"}  
  UPK3A                             [\*\*](#nt107){ref-type="table-fn"}                                        0.159784                              0.320718                
  UPK3B                             [\*\*](#nt107){ref-type="table-fn"}                                        0.281346                              0.376946                
  CLDN8                             [\*\*](#nt107){ref-type="table-fn"}                                        0.398229                 [\*\*](#nt107){ref-type="table-fn"}  
  CLDN10                            [\*\*](#nt107){ref-type="table-fn"}                                        0.448328                               0.46717                
  CLDN23                            [\*\*](#nt107){ref-type="table-fn"}                                         0.48318                              0.495167                
  JAM4                                                                                            [\*\*](#nt107){ref-type="table-fn"}                0.374898                 0.446032

All values shown ≥2-fold and p\<0.05.

Value \<2-fold and/or p≥0.05.

10.1371/journal.pntd.0001912.t006

###### Pathways analysis reveals differential transcription of multiple gene members of the vascular endothelial growth factor-related pathway five weeks post-egg exposure.

![](pntd.0001912.t006){#pntd-0001912-t006-6}

  ENTREZ GENE ID                                          GENE NAME
  ---------------- ---------------------------------------------------------------------------------------
  19354                                     RAS-related C3 botulinum substrate 2
  27371                                             SH2 domain protein 2A
  15507                                             heat shock protein 1
  18018                   nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
  18707             phosphatidylinositol 3-kinase catalytic delta polypeptide; RIKEN cDNA 2610208K16 gene
  30955                            phosphoinositide-3-kinase, catalytic, gamma polypeptide
  234779                                          phospholipase C, gamma 2
  19057                            protein phosphatase 3, catalytic subunit, gamma isoform

All genes shown featured ≥2-fold differential transcription and p\<0.05.

10.1371/journal.pntd.0001912.t007

###### Pathways analysis reveals differential transcription of multiple gene members of oncogene-related pathways five weeks post-egg exposure.

![](pntd.0001912.t007){#pntd-0001912-t007-7}

  ENTREZ GENE ID                             GENE NAME
  ---------------- -------------------------------------------------------------
  12143                                  B lymphoid kinase
  66813                        BCL2-like 14 (apoptosis facilitator)
  14281                              FBJ osteosarcoma oncogene
  14191             Gardner-Rasheed feline sarcoma viral (Fgr) oncogene homolog
  16909                                  LIM domain only 2
  14159                               feline sarcoma oncogene
  17095                             lymphoblastomic leukemia 1
  16818                         lymphocyte protein tyrosine kinase
  20423                                   sonic hedgehog
  22324                                   vav 1 oncogene

All genes shown feature ≥2-fold differential transcription and p\<0.05.

10.1371/journal.pntd.0001912.t008

###### Pathways analysis reveals differential transcription of multiple gene members of mammary carcinogenesis-related pathways five weeks post-egg exposure.

![](pntd.0001912.t008){#pntd-0001912-t008-8}

  ENTREZ GENE ID                                           GENE NAME
  --------------------------- --------------------------------------------------------------------
  23960                                        2′-5′ oligoadenylate synthetase 1G
  53313                                      ATPase, Ca++ transporting, ubiquitous
  140703                                            EMI domain containing 1
  246256                                       Fc receptor, IgG, low affinity IV
  18194                                   NAD(P) dependent steroid dehydrogenase-like
  18104                                         NAD(P)H dehydrogenase, quinone 1
  229003                                             cDNA sequence BC006779
  13040                                                   cathepsin S
  58187                                                    claudin 10
  12262                                 complement component 1, q subcomponent, C chain
  93726                             eosinophil-associated, ribonuclease A family, member 11
  235439                                hect domain and RCC1 (CHC1)-like domain (RLD) 1
  14960, 14968                          histocompatibility 2, class II antigen A/E alpha
  14998                                    histocompatibility 2, class II, locus DMa
  14999                                    histocompatibility 2, class II, locus Mb1
  380794                       Ig heavy chain 3 (serum IgG2b); Ig heavy chain (gamma polypeptide)
  15894                                        intercellular adhesion molecule 1
  68713                                    interferon induced transmembrane protein 1
  107321                                                    leupaxin
  109225                               membrane-spanning 4-domains, subfamily A, member 7
  17969                                          neutrophil cytosolic factor 1
  545007, 545013, 100040671                              alpha7-takusan
  16061, 100048770                          immunoglobulin heavy chain (J558 family)
  19283                           protein tyrosine phosphatase, receptor type Z, polypeptide 1
  20345                                      selectin, platelet (p-selectin) ligand
  19261                                         signal-regulatory protein alpha
  100044683                            Leucine rich repeat containing 8 family, member E
  100047788                              similar to gamma-2a immunoglobulin heavy chain
  100047619                         similar to solute carrier family 7 (y+ system), member 5
  21753                                            testis derived transcript
  17230                                              tryptase alpha/beta 1

All genes shown feature ≥2-fold differential transcription and p\<0.05.

*S. haematobium* eggs initiate differential transcription of extracellular matrix-associated genes in the bladder {#s3d}
-----------------------------------------------------------------------------------------------------------------

The presence of *S. haematobium* eggs in the bladder prompted complex patterns of differential transcription of multiple collagen and metalloproteinase genes over time ([Table 9](#pntd-0001912-t009){ref-type="table"}). We confirmed through Masson\'s Trichrome staining that transcription of these extracellular matrix-associated genes was temporally associated with bladder tissue remodeling and fibrosis ([Figure 5](#pntd-0001912-g005){ref-type="fig"}).

![*S. haematobium* egg-injected bladders develop fibrosis.\
Egg-injected bladders demonstrate histologically-apparent fibrosis within granulomata (right column, sections from week 3 post-egg injection bladder, Masson\'s Trichrome stain, collagen stains blue; left column, sections from week 3 post-control vehicle injection bladder show no granuloma and normal collagen staining pattern).](pntd.0001912.g005){#pntd-0001912-g005}

10.1371/journal.pntd.0001912.t009

###### Extracellular matrix-related genes featuring altered transcription by microarray analysis.

![](pntd.0001912.t009){#pntd-0001912-t009-9}

  Gene       Fold-Regulation Post-Injection Relative to Control[\*](#nt111){ref-type="table-fn"}                                                                              
  --------- ------------------------------------------------------------------------------------- ------------------------------------- ------------------------------------- -------------------------------------
  COL3A1                             [\*\*](#nt112){ref-type="table-fn"}                                        0.302919                              0.258949                
  COL4A5                             [\*\*](#nt112){ref-type="table-fn"}                                        0.437578                 [\*\*](#nt112){ref-type="table-fn"}  
  COL6A3                             [\*\*](#nt112){ref-type="table-fn"}                                        0.448199                 [\*\*](#nt112){ref-type="table-fn"}  
  COL8A2                             [\*\*](#nt112){ref-type="table-fn"}                                        0.457323                 [\*\*](#nt112){ref-type="table-fn"}  
  COL17A1                            [\*\*](#nt112){ref-type="table-fn"}                                         3.59083                              3.392723                
  COL7A1                             [\*\*](#nt112){ref-type="table-fn"}                                         2.00841                               2.16737                
  TIMP1                                                                                                          6.01549                              7.713105                               3.41333
  MMP10                                            8.79182                                                       18.2758                               11.5372                
  MMP13                                            4.98769                                                       16.2878                               5.75328                
  MMP3                                                                                                           2.21056                              3.203963                              3.084574
  MMP9                                                                                             [\*\*](#nt112){ref-type="table-fn"}                 3.90035                 [\*\*](#nt112){ref-type="table-fn"}

All values shown ≥2-fold and p\<0.05 unless otherwise noted.

Value \<2-fold and/or p≥0.05.

Discussion {#s4}
==========

Although *S. haematobium* infection is one of the most important causes of helminth-related mortality worldwide, research on this important parasite has suffered due to a lack of high fidelity animal models. We recently demonstrated that direct injection of *S. haematobium* eggs into the bladder walls of mice recapitulates many features of human urogenital schistosomiasis, including granulomatous inflammation, urothelial hyperplasia, egg shedding, and bladder fibrosis [@pntd.0001912-Fu1]. Since oviposition is induced at a precisely known time point, our synchronous granuloma model is ideal for dissecting the initial biological responses that occur in the bladder after egg exposure. We applied gene microarray approaches to our mouse model in order to interrogate the early molecular events associated with the bladder sequelae of urogenital schistosomiasis. This first-ever microarray analysis revealed complex modulation of multiple genes, with a peak occurring 3 weeks after egg exposure. As expected, type 2 inflammation- and macrophage function-associated gene transcription was increased. Extracellular matrix remodeling-related gene transcription was differentially modulated over time. Pathways analysis pointed to differential transcription of multiple genes implicated in carcinogenesis. Surprisingly, microarray analysis uncovered decreased transcription of certain tight junction and all uroplakin genes, which occurred despite urothelial hyperplasia.

Clearly, *S. haematobium* eggs induced a complex bladder gene response that waxed and waned during the time course examined. Few genes were differentially transcribed one week after bladder injection with *S. haematobium* eggs. By three weeks after egg injection of the bladder, the numbers of differentially transcribed genes had peaked. For example, by five weeks post-egg injection, the pool of differentially transcribed genes was already contracting. This suggests that the chronic bladder changes seen in urogenital schistosomiasis cannot be sustained by a single set of eggs; rather, it is driven by continuous oviposition by adult worms. In this model, successive waves of oviposition, rather than any lone egg bolus (such as that featured in our model), would sustain a long-term bladder response. This is consistent with observations that early stage schistosomal urinary tract pathology eventually resolves after praziquantel therapy-induced worm death (which leads to cessation of oviposition) [@pntd.0001912-Richter1]. Regardless, our single bolus model of synchronous granuloma formation proved valuable for characterizing the earliest molecular events in the bladder that occur in response to exposure to *S. haematobium* eggs.

As expected, many of the early molecular events in the bladder were related to granulomatous type 2 inflammation. Schistosome eggs are potent inducers of granuloma formation in various tissues, including the intestines, liver, lung, and bladder. These granulomata feature various leukocyte subsets, including eosinophils, neutrophils, lymphocytes, macrophages, and epithelioid cells (activated macrophages). Pathways analysis suggested a role for B cells, given that a number of relevant genes were differentially transcribed. We suspect that many of these genes promote immunoglobulin functions, including those involved with IgE, the isotype most commonly associated with helminth infection (reviewed by Erb [@pntd.0001912-Erb1]). Accordingly, our mouse model features IgE production [@pntd.0001912-Fu1]. Granuloma formation in mouse models of *S. mansoni* and *Schistosoma japonicum* infection (i.e., hepatoenteric schistosomiasis) is associated with a local and systemic type 2 inflammatory response [@pntd.0001912-Xu1], [@pntd.0001912-Hewitson1]. This immune polarization typically features elevated levels of IL-4 and IL-13 which trigger alternative activation of macrophages. These macrophages selectively metabolize arginine through arginase-1, whereas their classically activated counterparts convert arginine to nitric oxide through nitric oxide synthase [@pntd.0001912-Munder1]--[@pntd.0001912-Modolell1]. In our mouse model of urogenital schistosomiasis we have demonstrated that bladder granuloma formation is likewise associated with mixed leukocyte infiltration and regional and systemic production of type 2 cytokines [@pntd.0001912-Fu1]. Herein we have extended these findings by confirming granulomatous inflammation at additional time points and enhanced gene transcription for several chemokines, IL-4, the alternatively activated macrophage markers arginase-1, mannose receptor, and Ym-1/CHI3L3, and other indicators of type 2 inflammation. Although IL-13 gene transcription was unchanged, we have previously documented elevated protein levels of this cytokine from 1 through 4 weeks post-egg injection [@pntd.0001912-Fu1]. IL-13 has been implicated as a major mediator of fibrosis associated with *S. mansoni* egg exposure [@pntd.0001912-Chiaramonte1]--[@pntd.0001912-Singh1]. The pro-fibrogenic role of IL-13 is kept in check by the decoy receptor IL-13 receptor alpha 2 [@pntd.0001912-Madala1], [@pntd.0001912-Chiaramonte3]--[@pntd.0001912-Wynn1]. Indeed, transcription of the IL-13 receptor alpha 2 gene was increased in our model, suggesting a possible role in negative feedback on IL-13-mediated fibrosis. Other genes with dampening influences over *S. mansoni*-induced inflammation and fibrosis include RELM-alpha/Fizz1 [@pntd.0001912-Pesce1],[@pntd.0001912-Nair1], IL-10 [@pntd.0001912-MentinkKane2], [@pntd.0001912-Fairfax1]--[@pntd.0001912-Wynn2], and arginase [@pntd.0001912-Pesce2]. Of these three mediators, only arginase featured increased transcription (although IL-10 receptor alpha, but not IL-10, also demonstrated enhanced transcription). Thus, we hypothesize that arginase may have a role in resolving bladder fibrosis. Additional studies will be necessary to clarify this issue. Finally, the observed protein expression of arginase-1 and lack of increased iNOS transcription is consistent with selective polarization of macrophages along the alternative activation program.

Another relevant issue is whether the immune and fibrosis responses to *S. haematobium* eggs in the bladder differ from those directed against *S. mansoni* eggs in other tissues. Perhaps the most appropriate comparisons can be made between our data and microarray analyses that have employed the *S. mansoni* egg-induced, synchronous lung granuloma model [@pntd.0001912-Global1], [@pntd.0001912-Wilson1]. These studies are methodologically analogous to this study\'s microarray analysis of our synchronous egg injection model. Numerous immune and fibrosis response genes feature increased transcription in both the *S. mansoni* and *S. haematobium* models. These genes include those encoding for CCL4 (MIP-1β), IL-4 induced 1, IL-6, cytokine inducible SH2-containing protein (CISH), C1q, IgG Fc receptors, eosinophil ribonucleases, arginase, arachidonate 15-lipoxygenase (ALOX15), platelet thromboxane A synthase 1 (TBXAS1), MMP9 and MMP13. Nonetheless, several notable genes showing elevated transcription in the *S. mansoni* studies did not feature differential transcription in our datasets, namely MCP1 (CCL2), CCR9, MCP2 (CCL8), and MMP12. The transcription patterns for MMP9, MMP12, and MMP13 may reflect distinct collagen-remodeling pathways in *S. mansoni* lung versus *S. haematobium* bladder fibrosis. Surprisingly, some genes with increased transcription in Th1-skewed mouse strains from the *S. mansoni* studies were also increased in our microarray analysis, which was based on the Th2-skewed BALB/c strain. These genes include IL-1β, interferon gamma-inducible proteins, CCL5 (RANTES), and macrophage-expressed gene 1 (MPEG1). Hence, our model seems to feature increased transcription of a greater mix of type 1 and 2 immune response-associated genes as compared to the *S. mansoni* studies. We conclude that although the *S. haematobium* egg-directed immune and fibrotic response in the bladder shares many similarities to the *S. mansoni* egg-triggered lung response, there are a number of potentially important disparities. There is a precedent in the literature for schistosome- and tissue-specific immune and fibrotic responses. Liver- and lung-associated, *S. mansoni* egg granulomata develop in a highly organ-specific fashion [@pntd.0001912-Edungbola1]. *S. japonicum* granulomata also evolve in a tissue-specific manner in the liver, lung, and intestinal tract [@pntd.0001912-Hirata1]. These reports highlight the critical need to develop *in vivo* models which properly match schistosome species with their tropism for specific host organs.

Besides validating our prior immunologic- and fibrosis-related observations, microarray analysis also identified complex modulation of genes integral to urothelial function. Uroplakins are key structural proteins that form organized plaques on the surface of urothelial cells. The coordinated expression of the various uroplakin genes is believed to confer both impermeability and flexibility to the urothelium. These two functions are critical to the bladder\'s ability to safely sequester accumulating urine and expel it during micturition. Accordingly, mice deficient for various uroplakins exhibit bladder dysfunction and increased urothelial permeability [@pntd.0001912-Hu1], [@pntd.0001912-Aboushwareb1]. We were intrigued by the finding that the transcription of all uroplakin genes was dampened at three weeks after *S. haematobium* egg introduction to the bladder. Other workers have reported less uroplakin gene transcription and urothelial hyperplasia after administration of disparate noxious stimuli to the bladder, including Bacillus Calmette-Guerín (BCG) [@pntd.0001912-Saban1], cyclophosphamide [@pntd.0001912-Kyung1]--[@pntd.0001912-Romih1], and an *in vitro* model of culture media-induced urothelial hyperplasia [@pntd.0001912-Vinjar1]. Urothelial hyperplasia in this setting is a secondary response to reseal urothelial defects that have resulted from desquamation of dead urothelial cells [@pntd.0001912-Veranic1], [@pntd.0001912-Veranic2]. Strikingly, this urothelial response appears to be conserved across species, given that these studies have encompassed mice, rats, and pigs. To our knowledge, we report here the first characterization of uroplakin changes triggered by urogenital schistosomiasis. In our past work we have identified the onset of urothelial hyperplasia after *S. haematobium* egg injection [@pntd.0001912-Fu1], and herein have corroborated this at other time points. Taken together, this suggests that decreased uroplakin gene transcription and urothelial hyperplasia are coupled processes that are part of a conserved bladder response to a range of forms of urothelial injury. In our model, decreased transcription of uroplakin genes and urothelial hyperplasia occurs in the setting of egg shedding in urine. We speculate that *S. haematobium* eggs induce, or at least exploit, the compromised urothelial barrier (i.e., decreased uroplakins) to pass into urine. These possibilities highlight the complex dynamics of urothelial biology in urogenital schistosomiasis. Our findings also underscore the importance of high fidelity urogenital schistosomiasis models. Namely, extrapolation of *S. haematobium* urogenital disease mechanisms from *S. mansoni* hepatoenteric disease models is not possible, given the tissue-specific expression of uroplakins.

Loss of uroplakin expression has been noted in some urothelial cancers [@pntd.0001912-Matsumoto1], [@pntd.0001912-Olsburgh1]. Although it is tempting to causally link these observations to our findings and schistosomal bladder cancer, the lack of reports of development of bladder cancer in uroplakin-deficient mice suggests that loss of uroplakin expression may not be carcinogenic. Conversely, we identified differential transcription of genes implicated in multiple carcinogenesis pathways, including vascular endothelial growth factor (VEGF)-, oncogene-, and mammary tumor-related genes. Tissue, plasma, and urine levels of VEGF have been reported to be elevated in patients with schistosomal bladder cancer [@pntd.0001912-Salem1]. Our past work is consistent with these findings in that bladder VEGF increases after egg injection [@pntd.0001912-Fu1]. We speculate that elevated VEGF in the bladder may promote cancer progression by stimulating tumor vasculogenesis. In addition, we also conjecture that VEGF mediates growth of abnormal, friable blood vessels which rupture and leak blood through the uroplakin-poor, compromised urothelium, ultimately resulting in the hematuria associated with urogenital schistosomiasis.

Additional evidence for a compromised urothelial barrier was identified in the form of dampened transcription of tight junction-related genes. While uroplakins contribute to the urothelium\'s water and urea permeability barrier, tight junctions have a complementary role. These structures confer transmembrane epithelial resistance to the urothelium [@pntd.0001912-Hu2]. We found that gene transcription of claudin-8 and junctional adhesion molecule-4, components of tight junctions in the bladder urothelium [@pntd.0001912-Vinjar1], [@pntd.0001912-Acharya1]--[@pntd.0001912-SnchezFreire1], was lessened after egg injection. Bladder urothelial tight junction expression of claudins and junctional adhesion molecules is found in rats, mice, rabbits, pigs, and humans, which highlights the tight conservation of these genes across mammalian species and hints at their biological importance.

Bladder fibrosis, disorganized deposition of extracellular matrix in the bladder wall, is another critical biological process associated with urogenital schistosomiasis. We have previously reported induction of bladder fibrosis after *S. haematobium* egg injection that resembles human disease [@pntd.0001912-Fu1]. Here, we also histologically confirmed fibrosis at additional time points that correlated with fibrosis-related gene transcription. Specifically, we identified augmented transcription of the collagen genes COL7A1 and COL17A1, metalloproteinases-3, -9, -10, and -13, and tissue inhibitor of metalloproteinase 1 (TIMP1). Interestingly, transcription of other collagen genes, i.e., COL3A1, COL4A5, COL6A3, and COL8A2, were decreased after egg injection. Normal levels of COL3A1 have been shown through transgenic mouse studies to be important for proper bladder function [@pntd.0001912-Stevenson1]. In addition, MMP9, MMP13, and TIMP1 are expressed in many bladder cancers and may mediate tumor invasiveness through extracellular matrix regulation [@pntd.0001912-Bostrm1], [@pntd.0001912-Staack1]. The differential transcription of numerous genes linked to extracellular matrix remodeling underscores the intricate fibrosis- and cancer-promoting pathways associated with schistosomal granuloma formation.

Although our findings are highly informative, the employed mouse model features limitations. Since *Mus musculus* and *S. haematobium* are both eukaryotes, theoretically speaking these species may feature homologous genes. However, we believe that the probability of orthologs sharing significant nucleotide homology is quite low. Codon usage in mice and trematodes such as *S. haematobium* is different, as exemplified by the need for codon optimization to maximize expression of *Schistosoma* genes by mammalian cells [@pntd.0001912-Zhu1], [@pntd.0001912-Hamdan1]. Moreover, we only injected 3000 eggs per mouse bladder, and eggs are shed in the urine over time. Hence, *S. haematobium* RNA is only a small fraction of the total RNA in egg-injected mouse bladder tissue, making it unlikely that *S. haematobium* cRNA hybridization to microarray chips (if any) significantly affected our analysis. Another limitation is that our egg injection model does not reproduce the entire *S. haematobium* life cycle of the human host. Cercariae are found in the skin and subcutaneous tissues, schistosomula circulate in the systemic and portal circulation, and adult worms reside in the pelvic venous plexus. However, for the purposes of this bladder-focused study, eggs are sufficient since it is the only *S. haematobium* life stage present in bladder tissue. It is also possible that *S. haematobium* eggs transferred from hamsters (the source of eggs in our model) to a final mouse host may be metabolically and immunologically distinct from eggs laid *in situ* in a single mouse host. This has been postulated to occur with *S. japonicum* eggs [@pntd.0001912-Hirata1]. We have controlled for this in part by using control injections of hamster liver and intestine-derived "vehicle". However, studies are underway to compare *in vitro* laid eggs to hamster-derived eggs in our mouse model. The single, large egg bolus utilized in our model is unlikely to reflect the kinetics of continuous oviposition in the human host. On the other hand, our model features highly focal, coalescing multiple egg-based granulomata that are reminiscent of those observed in the human bladder [@pntd.0001912-Cheever1]. Regardless of these issues, our model mitigates the relative scarcity of early disease stage bladder tissue available for research. Bladder tissue from schistosomiasis patients is typically only available from those undergoing cystectomy or bladder reconstructive surgery for advanced bladder cancer or fibrosis, respectively. Thus, our model fills an important niche in basic research on urogenital schistosomiasis.

In conclusion, we have defined for the first time the initial molecular underpinnings of the bladder response to *S. haematobium* eggs in an experimental model of urogenital schistosomiasis. Although this response is manifold, it is discrete, involves known inflammatory, fibrosis, epithelial, and cancer-related pathways, and expands and contracts over time. This work may direct future efforts to develop diagnostic and therapeutic tools for the bladder sequelae of urogenital schistosomiasis and potentially cancers and inflammatory disorders of the bladder in general.
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**Functional annotation clustering of differentially transcribed genes in egg-injected mice.** All genes shown featured ≥2-fold differential transcription and p\<0.05.

(DOCX)
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Click here for additional data file.

###### 

**Illumina probe IDs and Entrez Gene IDs of differentially transcribed genes.** All genes shown featured ≥2-fold differential transcription and p\<0.05. Entrez Gene IDs and descriptions were not available for some genes.

(XLSX)

###### 

Click here for additional data file.

###### 

**Primers used for real-time PCR validation of microarray data.** Primer sequences were derived from PrimerBank (<http://pga.mgh.harvard.edu/primerbank/>).

(XLSX)

###### 

Click here for additional data file.
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